Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer

Clinical trial NCT05878314 · RECRUITING

Trial details

NCT number: NCT05878314
Sponsor: University Hospital Tuebingen
Status: RECRUITING
Study type: OBSERVATIONAL

Hormone Receptor Positive HER-2 Negative Breast Cancer

Start date: 2023-04-25
Primary completion: 2027-04-01
Enrollment: 504

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.